Peer Review History

Original SubmissionJanuary 28, 2021
Decision Letter - Jamie Males, Editor
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

PONE-D-21-03042

Exploring the Factors Associated with the Mental Health of Frontline Healthcare Workers during the COVID19 pandemic in Cyprus

PLOS ONE

Dear Dr. Kapetanos,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please ensure that you carefully address all of the points raised by the reviewers when preparing your revisions. Please pay particular attention to explaining the aspects of your study design and methods that the reviewers have indicated need further clarification.

Please submit your revised manuscript by Aug 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jamie Males

Staff Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Methods section, please provide a justification for the sample size used in your study, including any relevant power calculations (if applicable).

Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was suitably informed and (2) what type you obtained (for instance, written or verbal). If your study included minors under age 18, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

In Table 1 please clarify how BMI was  measured for all participants, and please provide a justification in the Methods section regarding the selection of BMI as a study variable. Should this variable be reported as the 'MBI score'  please correct the table accordingly.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for your submission. I believe the topic is very timely and interesting to the readers of PLOS ONE. However, there are few points to be considered revision.

[major revision]

1. It is not very clear why you needed to display the data separately for each six facilities. It gives an impression that this is not the common results that can be applied to other facilities. You may consider only displaying the results of all facilities together or state in the method/results why it need to be displayed separately.

2. I believe the significance of your manuscript is the mixed method (using both quantitative and qualitative data). and the findings from the qualitative data were very impressive. Would you consider discussing deeper regrading your findings? (ie., This qualitative data could explain why people does/doesn't burn out.)

[minor revision]

1. in line 176, change "Maslach Burnout Inventory (MBI)" to "MBI", since you have already explained the acronym in line 170.

2. tables and figures are not very easy to read. you may consider adding vertical lines appropriately.

3. for table 3, you may add the percentage of each numbers (not just in the text), so the reader can understand the weight of each theme.

Reviewer #2: Dear authors,

Firstly, I would like to congratulate you for the research you carried out, as it focus on a relevant topic and seems to have have been carried out with rigor. However, there are some issues you must address:

1) The use of the English language is not bad, but there are some typographical errors along the manuscript. Thus, I think your paper must be proofread by a native professional translator.

2) Although your paper presents some interesting information and findings, it is extremely long, so, it is not "reader-friendly". I recommend you keep the essential information in the manuscript and present the additional information in supplementary files.

3) A lot of research has already been conducted on this topic and, indeed, your paper does not add new knowledge. It just presents national data but you should not forget that PLOS ONE is a journal which is read by an international audience. Thus, you must make clear what your paper adds to the body of knowledge on that domain, and why it is relevant for an international audience.

4) You stated that data collection was carried out in several hospitals and that your sample was composed by 381 healthcare workers. But, to how many healthcare workers did you send the questionnaire? I mean, what was the response rate? That information is quite important and, if there is a low response rate, that can be a significant limitation of your study.

5) You included in your sample cleaning staff. Why did you consider cleaning staff as healthcare workers? That is a bit strange. If you really want to keep that staff in your sample, you should present a clear definition of "healthcare workers" in which it would make sense to include cleaning staff.

6) You use the term "frontline healthcare worker" several times along the manuscript. If you really want to use that term, you must clearly define what is a "frontline healthcare worker". However, that is not really a good term, as it is much more journalistic than scientific.

7) You presented an explanation of Cyprus response to the pandemic. However, you did not present the pandemic situation in Cyprus during the period of data collection, and that would be quite relevant. How many cases per day? How many hospitalizations per day? How many deaths per day? Was data collection carried out in the peak of a covid-19 wave or in a more stable period?

8) You must specify a bit more the data collection procedures. Who did send the questionnaires to the potential participants? The research team? How did you access the e-mail address of the participants? Did you send reminders? How many? Or was the questionnaire sent by the hospital? How may those options have influenced your results? How did you collect paper versions of the questionnaire? Was not Cyprus in lockdown during that period?

9) Were the assessment tools (MBI and DASS21) validated for the Cyprus population? If yes, you should present the most relevant psychometric properties of those tools in its version validated for the Cyprus population.

10) Did you pretest the questionnaire, considering there were some question which were developed by the research team? If yes, with ho many participants? What was their feedback on the data collection tool?

11) You stated that (line 218): "Variables with a p value < 0.15 at the univariable analysis were considered foe inclusion in the multivariable models". Did you mean "p value < 0.05". Or, if you really mean p < 0.15, why that option (which is not quite usual)?

12) In line 230 you stated that "the responses were split into six thematic categories, depending on the conceptual interpretation of the content". Were those categories predefined or they emerged from the thematic analysis?

13) In line 472 you stated that "a notable strength is the large sample size, collected across multiple centres throughout the nation. This allowed for a representative sample population". However, having a large sample (and your sample, indeed, is not that "large") does not guarantee a sample is representative. How can you assume that your sample is representative?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Thank you very much for your consideration and your feedback. Please find all our comments included in the "Response to reviewers" letter, that has been attached alongside the manuscript.

Attachments
Attachment
Submitted filename: Response to Reviewers .docx
Decision Letter - Francisco Sampaio, Editor

Exploring the Factors Associated with the Mental Health of Frontline Healthcare Workers during the COVID19 pandemic in Cyprus

PONE-D-21-03042R1

Dear Dr. Kapetanos,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Francisco Sampaio, Ph.D.

Guest Editor

PLOS ONE

Additional Editor Comments (optional):

Dear authors,

Your paper was revised once again by two independent reviewers. According to their opinion, all their previous comments were successfully addressed, so your paper can now be accepted for publication. Congratulations for that!

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for revising the manuscript following reviewers suggestions. The significance of your manuscript which is the mixed method (using both quantitative and qualitative data) are strengthened and I believe your manuscript is now ready for publication. Thank you for submitting such a timely and inspiring manuscript. I believe your findings would help many healthcare practitioners around the world.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Formally Accepted
Acceptance Letter - Francisco Sampaio, Editor

PONE-D-21-03042R1

Exploring the Factors Associated with the Mental Health of Frontline Healthcare Workers during the COVID19 pandemic in Cyprus

Dear Dr. Kapetanos:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Francisco Sampaio

Guest Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .